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1. Introduction
Enterohepatic Helicobacter species (EHS) colonize the 
lower intestine and hepatobiliary tract of a broad range of 
hosts including human [1]. Certain EHS cause enterocoli-
tis and bacteremia in humans immunocompromised due to 
AIDS [2] and chronic colitis and hepatitis in laboratory an-
imal models  [3,4]. The prototype EHS, Helicobacter he-
paticus, is a cause of typhlocolitis, hepatitis, and hepato-
cellular carcinoma in laboratory mice, and together with 
certain EHS produces a toxin, known as cytolethal distend-
ing toxin (Cdt) [5]. Homologues of EHS Cdt also are found 
in the enteric bacterial pathogens, Campylobacter species, 
Shigella species, and Escherichia coli as well as the peri-
odontopathogenic bacterium, Actinobacillus actinomy-
cetemcomitans and the venereal pathogen, Haemophilus 
ducreyi [6,7].
In concert with subunits A and C, Cdt subunit B (cdtB) 
causes progressive cytoplasmic and nuclear distension of 
target cells accompanied with growth arrest at the G2/M 
transition phase of the eukaryotic cell cycle, and ultimately 
cell death  [7–10]. More recent studies suggest that CdtB 
produced by H. hepaticus [5], Campylobacter jejuni [11], 
E. coli [12], and Shigella dysenteriae [13] might be an im-
portant virulence determinant in naturally-occurring and 
experimentally-induced disease.
The presence of conserved cation-binding and DNA 
catalysis residues between CdtB and members of the 
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Abstract: The cytolethal distending toxin B (CdtB) of the mouse pathogen Helicobacter hepaticus has cation 
binding and DNA catalysis residues in common with members of the mammalian deoxyribonuclease I (DNase I) 
family. The purpose of the present study was to characterize CdtB nuclease. To establish optimal digestion con-
ditions and to evaluate co-factor requirements, a novel and sensitive fl uorometric assay that quantitatively de-
termines double stranded DNA digestion was developed. Although the Ca2+- and Mg2+-dependence and neutral 
properties of CdtB were similar to DNase I, hydrolysis of DNA by CdtB was approximately 100-fold less active 
than DNase I and was considerably more resistant to inhibition by ZnCl2 and G-actin.
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mammalian deoxyribonuclease I (DNase I) family was in-
dependently reported by Elwell and Dreyfus for E. coli 
[8,10] and Lara-Tejero and Galán for C. jejuni [9]. DN-
ase I is an endonuclease that digests single- and double-
stranded DNA (dsDNA) by hydrolyzing phosphodiester 
bonds producing mono- and oligo-deoxyribonucleotides 
with 5’-phosphate and 3’-hydroxyl groups. Consistent 
with the structural similarities with DNase I, mutations of 
corresponding residues impaired the nuclease activity of 
E. coli CdtB in vitro [8]. However, demonstration of the 
nuclease activity of CdtB in vitro has only been shown 
by qualitative assessment of plasmid DNA digestion with 
CdtB of E. coli [8,10], and more recently H. hepaticus 
[14], and eukaryotic DNA double strand breaks with CdtB 
of H. ducreyi [7,15] by using gel-based assays. Diges-
tion of plasmid DNA by CdtB under empiric conditions 
is estimated on the basis of disappearance of supercoiled 
form in agarose gels stained with ethidium bromide. Al-
though this method is suitable for qualitative demonstra-
tion of nuclease activity, the detection limit is low, approx-
imately 10 ng plasmid DNA, and does not allow precise 
biochemical characterization of nuclease activity, partic-
ularly determination of optimal assay conditions, co-fac-
tor requirements, and comparative digestion effi ciency 
and inhibition. To address these limitations, hexahistidine 
(His6)-tagged CdtB was overproduced and purifi ed from 
the prototype pathogenic EHS, H. hepaticus, and a highly 
sensitive fl uorometric assay that accurately quantitates ds 
DNA digestion was developed. The fl uorometric assay 
uses the dye PicoGreen that selectively binds to dsDNA in 
solution and displays a linear correlation between dsDNA 
concentration and fl uorescence with a detection range of 
25 pg ml–1 –1 μg ml–1 dsDNA [16]. PicoGreen is a cationic 
bis-cyanine dye with very low fl uorescence quantum yield 
in solution that changes to very high yield when it bis-in-
tercalates into duplex DNA. The basis of the fl uoromet-
ric nuclease assay is that a fractional decrease in fl uores-
cence intensity of the PicoGreen–DNA complex is exactly 
proportional to the hydrolysis of a fractional equivalent of 
phosphodiester bonds in the dsDNA sample. As the duplex 
DNA is cleaved, termini are created to which the dye binds 
poorly. The fl uorometric assay can not differentiate enzy-
matic cleavage of supercoiled plasmid DNA to linear and 
relaxed forms seen with the gel-based assay used in pre-
vious studies. However, it provides a highly sensitive and 
quantitative measure of nuclease activity unlike the sub-
jective assessment of plasmid digestion in the gel-based 
assay. The data provide new insights into DNA hydrolysis 
by H. hepaticus CdtB, a representative member of a novel 
family of nuclease toxins produced by several important 
bacterial pathogens of humans and animals.
2. Materials and methods
2.1. Bacterial strains and growth conditions
H. hepaticus mouse strain 3B1/Hh-1 ATCC 51449T [3] 
was propagated on trypticase soy agar supplemented with 
5% (v/v) sheep blood incubated at 37 °C under micro-
aerobic conditions as previously described [17]. Chemi-
cally competent E. coli (One Shot TOP10 and BL21 Star 
[DE3] strains; Invitrogen, Carlsbad, CA) were grown on 
Luria–Bertani (LB) agar plates at 37 °C under aerobic 
conditions. Transformants were selected by plating onto 
LB agar containing 30 μg ml 1 (w/v) kanamycin (Sigma, 
St. Louis, MO).
2.2. His6-tagged H. hepaticus CdtB
The cdtB gene of H. hepaticus was amplifi ed by using a 
PCR assay with forward 5’-GAATTC AATCTTGAAGAT-
TATAGAG-3’ and reverse 5’-CTCGAGCTAAAATCGTC-
CAAAATGC-3’ oligonucleotide primers designed to am-
plify the full length gene without the fi rst 48 nucleotides 
encoding the N-terminal 16-amino acid signal sequence 
(GenBank accession no. AF163667/AAF19158). One hun-
dred ng of H. hepaticus genomic DNA was mixed with 48 
μl containing 1× PCR buffer, 1.5 mM MgCl2, 0.2 mM con-
centration each of dATP, dTTP, dGTP, and dCTP, 0.5 μM 
concentration of each primer, and 1.0 U of the high fi del-
ity Pfx DNA polymerase (AccuPrime, Invitrogen) in ster-
ile water. The cycling conditions consisted of an initial de-
naturation at 95 °C for 3 min, followed by 25 cycles of 
denaturation at 95 °C for 1 min, annealing at 52 °C for 1 
min, and extension at 68 °C for 1 min. The 771 bp am-
plifi ed product was visualized by electrophoresis in 0.8% 
agarose gel run at 7.0 V/cm after staining with ethidium 
bromide. For directional expression cloning into the His6-
tagged vector (Novagen, Madison, WI) 5’-Eco RI and 3’-
Xho I overhangs were included in the respective primers 
(underlined sequence). After digestion of purifi ed PCR 
products with appropriate restriction enzymes, the cdtB 
fragment was sub-cloned into pET-28a(+) (Novagen) and 
transformed into E. coli TOP10. The nucleotide sequences 
of both strands of plasmid DNA from selected recombinant 
clones were determined. The correct His6-tagged CdtB con-
struct was transformed into E. coli BL21 and induced with 
1 mM isopropyl-β-d-thiogalactopyranoside (IPTG, Invitro-
gen) at 25 °C for 5 h. At the end of the incubation, the cells 
were harvested by centrifugation and suspended in binding 
buffer (0.5 M NaCl, 20 mM Tris–HCl, 5 mM imidazole, 
pH 7.9; Novagen) containing 45–60 KU g 1 of lysozyme 
(Sigma). The cells were lysed by sonication and after cen-
trifugation at 14,000g for 20 min at 4 °C, CdtB was pu-
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rifi ed from the soluble (supernatant) and insoluble (pellet) 
fractions. Purifi cation of CdtB from the soluble fraction 
was accomplished under native conditions with a 1.25 ml 
Ni2+-charged His-Bind column (Novagen). The insoluble 
CdtB fraction was purifi ed under denaturing conditions by 
adding 6 M urea. The eluted CdtB was diluted in dialysis 
buffer (25 mM Tris–HCl, 25 mM NaCl, 2 mM EDTA, pH 
7.4) to 0.1 mg ml 1 and dialyzed (6 K MWCO Spectra, 
Spectrum, Medical Industries Inc., Los Angeles, CA) over-
night at 4 °C. The urea was removed gradually during dial-
ysis by sequential changes of dialysis buffer that contained 
4, 2, and then 0 mM urea, to provide gradual re-folding of 
CdtB. The soluble CdtB and the re-solubilized CdtB were 
separately concentrated and desalted by fi lter centrifugation 
(Amicon Ultra-15 10K MWCO; Millipore, Bedford, MA) 
at 3000g for 30 min at 4 °C. The concentration of protein 
was determined by using a commercially available method 
(BCA protein assay kit; Pierce, Rockford, IL).
Purifi ed CdtB and whole-cell lysate from induced and 
noninduced E. coli BL21 cells were subjected to sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) with 4% stacking and 12% separation gel for 3 h 
at room temperature and staining with Coomassie brilliant 
blue R250 or electrotransferred onto nitrocellulose mem-
brane for immunoblot analysis [18]. Identifi cation of CdtB 
on the immunoblot was accomplished by incubation of the 
membrane with a mouse monoclonal anti-His6 tag immu-
noglobulin (Ig) G1 antibody (Novagen), followed by horse-
radish peroxidase conjugated goat anti-mouse IgG1 (heavy 
and light chains) antibody (Santa Cruz Biotechnology Inc., 
Santa Cruz, CA), and 4-chloro-1-naphtol substrate (Kirkeg-
aard & Perry Laboratories Inc., Gaithersburg, MD) and 
washings. The amino acid sequence of purifi ed His6-tagged 
CdtB was confi rmed by mass spectrometry [19].
2.3. Gel-based nuclease assay
The nuclease activity of the purifi ed His6-tagged CdtB 
was fi rst confi rmed by qualitative assessment of changes 
in band intensity after digestion of either purifi ed plasmid 
DNA (pUC19  [Invitrogen], pBSIIKS+  [Stratagene, La 
Jolla, CA] and pTRE2hyg  [Clontech]) or eukaryotic DNA 
from human epithelioid cervical carcinoma HeLa cells 
ATCC CCL-2, and separation of DNA fragments by elec-
trophoresis in agarose gels stained with ethidium bromide, 
as previously described  [8,14]. Briefl y, 1 μg (1.5 μM fi nal 
protein concentration) of CdtB and either 1 μg (150 μM fi -
nal nucleotide concentration) of plasmid DNA or eukary-
otic DNA in a volume of 20 μl of 50 mM HEPES, pH 7.4, 
10 mM MgCl2, 10 mM CaCl2, and 0.4 μg ml
1 bovine se-
rum albumin (BSA) were incubated for up to 6 h at 37 °C. 
At the end of the incubation, DNA digestion was stopped 
by adding sample loading buffer (50 mM EDTA, 0.25% 
bromphenol blue and 30% glycerol) and loading onto 0.8% 
agarose gel, and electrophoresis at 7.0 V/cm for 2 h. Disap-
pearance of supercoiled plasmid DNA and digestion of eu-
karyotic DNA were visualized under UV light after stain-
ing with ethidium bromide.
2.4. Fluorometric nuclease assay
Further quantitative determinations of the nuclease ac-
tivity of CdtB were accomplished by using the newly de-
veloped fl uorometric assay. Standard assay conditions for 
digestion consisted of 1 μg (1.5 μM fi nal protein concentra-
tion) CdtB mixed with 1 μg (150 μM fi nal nucleotide con-
centration) DNA in a volume of 20 μl of 50 mM HEPES, 
pH 7.5, 10 mM CaCl2, 10 mM MgCl2, and 0.4 μg ml
1 
BSA reaction buffer. After incubation for up to 6 h at 37 °C, 
the reaction was quenched by transferring 4 μl of the reac-
tion mixture to 96 μl of 10 mM Tris, pH 7.4, 1 mM EDTA 
buffer (TE), in a fl at-bottom 96-well plate (Nalge Nunc 
Intl., Naperville, IL). After diluting the DNA quantitation 
reagent (PicoGreen dsDNA Quantitation Reagent and Kits; 
Molecular Probes, Eugene, OR) to 1:200 into TE buffer, 
100 μl was added to each well and incubated at room tem-
perature for 3 to 5 min in the dark. After incubation, the 
fl uorescence was measured using a fl uorescence microplate 
reader (FLUOstar OPTIMA BMG LABTECH, Durham, 
NC) with excitation and emission wavelengths of 485 and 
520 nm, respectively. Data were expressed as mean percent 
digested ng ml 1 of ds DNA by determining the ratio of di-
gested to control undigested dsDNA in ng ml 1× 100 from 
at least three independent experiments, and using a stan-
dard curve with known DNA concentrations from 0 to 1 μg 
ml 1 (0 to 150 μM). Bovine pancreatic DNase I (0.1 U or 
3.7 μM; Fermentas, Hanover, MD) was included as a posi-
tive control in all of the assays. Negative control consisted 
of dsDNA without nuclease under the same conditions.
2.5. Multiplex reaction buffer and pH optimization and 
cation requirement
First, different concentrations of the reaction buffer 
HEPES pH 7.4 (0–100 mM) containing 0–50 mM CaCl2, 0–
50 mM MgCl2, and 0–100 μg ml
1 BSA were examined for 
digestion of 1 μg (150 μM nucleotide) plasmid DNA by 1 μg 
(1.5 μM) CdtB in a fi nal volume of 20 μl for 1 h at 37 °C.
Once the optimal DNA digestion conditions were deter-
mined, the pH dependence of CdtB nuclease activity was 
determined using a range of pH from 3 to 9 in 0.5 unit in-
crements by using APHTC buffer containing 40 mM each 
of acetic acid (pK 4.8 at 25 °C), PIPES (pK 6.8), HEPES 
(pK 7.6), Tris (pK 8.3), and CHES (pK 9.3) (Sigma). Then, 
HCl was added to half of the APHTC mixture to create so-
lutions with pHs from 3 to 6.5. Similarly, NaOH was added 
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to the other half of the mixture to create solutions with pHs 
from 7 to 9.
The cation requirement for nuclease activity of CdtB 
was determined by pre-incubating the reaction buffer con-
taining 1 μg (1.5 μM) CdtB with either 4 to 20 mM EDTA 
or 50 to 250 mM NaCl for 10 min at 37 °C. Then 1 μg (150 
μM nucleotide) plasmid DNA was added, and after adjust-
ing the fi nal volume to 20 μl with distilled water, the reac-
tion mixture was incubated at 37 °C before determination 
of the mean percent DNA digestion by using the fl uoromet-
ric assay. In order to assess the synergistic effect of Ca2+ 
and Mg2+, 0 to 50 mM of Mg2+ were assayed in the pres-
ence of 10 mM Ca2+ or 0 to 50 mM Ca2+ were assayed in 
the presence of 10 mM Mg2+.
Subsequent experiments examined the kinetics of 
plasmid DNA and eukaryotic DNA digestion for up to 6 
h, by using varying concentrations of CdtB from 0.2 to 2 
μg (0.3 to 3 μM) and constant 1 μg (150 μM nucleotide) 
dsDNA or keeping the concentration of CdtB constant at 
1 μg (1.5 μM) and varying the concentration of dsDNA 
from 0.1 to 2 μg (15 to 300 μM nucleotide) under optimal 
buffer conditions.
2.6. Inhibition of CdtB nuclease activity by ZnCl2 and 
G-actin
The requirement for Ca2+ and Mg2+ for CdtB nuclease 
activity was further examined by pre-incubating 1 μg (1.5 
μM) CdtB in reaction buffer containing 0.03 to 1.0 mM 
ZnCl2 for 15 min at 37 °C, then 1 μg (150 μM nucleotide) 
plasmid DNA was added and further incubated for up to 6 
h at 37 °C. G-actin has been shown to specifi cally inhibit 
mammalian DNase I  [20–22]. Following incubation of 1 
μg (1.5 μM) CdtB in reaction buffer containing between 1 
and 400 μg ml–1 rabbit skeletal muscle G-actin (Molecular 
Probes) for 20 min at 37 °C, 1 μg (150 μM nucleotide) plas-
mid DNA was added and further incubated for up to 6 h at 
37 °C. In control experiments, 0.1 U (3.7 μM) bovine pan-
creatic DNase Ipre-incubated with either ZnCl2 or G-actin, 
was allowed to digest 1 μg (150 μM nucleotide) plasmid 
DNA for 20 min at 37 °C. In all assays, the mean percent 
DNA digestion was quantifi ed using the fl uorometric assay.
3. Results and discussion
The single band with a molecular mass of approxi-
mately 32 kDa was present on the Coomassie blue stained 
SDS-PAGE of purifi ed protein (Fig. 1A). This mass was 
consistent with the predicted molecular mass of the re-
combinant H. hepaticus His6-tagged CdtB. The identity 
of the purifi ed recombinant CdtB protein was confi rmed 
by immunoblot analysis with anti-His6 antibody (Fig. 1B) 
and amino acid sequence determination by mass spec-
trometry.
Both the soluble and re-solubilized proteins were ac-
tive as determined in the gel-based assay. Incubation of ei-
ther plasmid or eukaryotic DNA with the purifi ed enzymes 
showed disappearance of supercoiled plasmid DNA over 6 
h incubation (Fig. 2) or digestion of eukaryotic DNA indic-
ative of nuclease activity.
Figure 1. SDS-PAGE and immunoblot analyses of recombinant H. hepati-
cus His6-tagged CdtB. SDS-polyacrylamide gel electrophoresis and stain-
ing with Coomassie brilliant blue R250 (A), and immunoblot analysis using 
a mouse monoclonal anti His-tagged IgG1 antibody followed by horseradish 
peroxidase-conjugated goat anti-mouse IgG1 antibody (B). Lanes: 1, molec-
ular weight marker; 2, whole-cell lysate of E. coli BL21 before IPTG induc-
tion; 3, whole-cell lysate of E. coli BL21 5 h after IPTG induction; 4, purifi ed 
CdtB from the soluble fraction (approx. 1 μg); and 5, purifi ed re-solubilized 
CdtB from the insoluble fraction (approx. 1 μg).
Figure 2. Nuclease activity of H. hepaticus CdtB with plasmid DNA. Purifi ed 
His6-tagged CdtB was incubated with plasmid DNA (pTRE2hyg, Clontech) 
in the presence of Ca2+ and Mg2+ for up to 6 h and supercoiled (S), linear (L), 
and relaxed (R) forms of plasmid DNA were stained with ethidium bromide 
after separation by electrophoresis in a 0.8% agarose gel. Lanes: 1, control 
undigested plasmid DNA; 2, 1 h; 3, 2 h; 4, 3 h; 5, 4 h; 6, 5 h incubation. The 
data are representative of three independent experiments.
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A rapid and quantitative fl uorometric assay was used 
for optimization of the enzyme, including co-factor re-
quirements, and then to characterized the inhibitory ef-
fects of Zn2+ and G-actin. Quantitative assessment of the 
nuclease activity of purifi ed CdtB by using the fl uoromet-
ric assay revealed that although 25 mM HEPES, 5 mM 
CaCl2, 5 mM MgCl2, and 100 μg ml
1 BSA had been em-
pirically used in a previous study [10], a fi nal concentra-
tion of 50 mM HEPES, 10 mM CaCl2, 10 mM MgCl2, 
and 0.4 μg ml 1 BSA provided optimal conditions for 
DNA digestion. Because the nuclease activities of CdtB 
obtained from the soluble fraction and the re-solubilized 
fraction were comparatively similar, CdtB obtained from 
the soluble fraction was used in all subsequent experi-
ments. Although DNA digestion was observed between 
pH 5 and 9, maximum DNA digestion was seen at neutral 
pH between 7 and 8.
Next, we evaluated the effi ciency of DNA digestion by 
varying the concentrations of CdtB and DNA, respectively. 
Because the digestion of 1 μg (150 μM nucleotide) plas-
mid DNA increased from 15% with 0.2 μg of CdtB to 40% 
with 1 to 2 μg of CdtB, a concentration of 1 μg (1.5 μM) 
of CdtB was used in all subsequent experiments. When in-
creasing concentrations of plasmid DNA from 0.1 to 2 μg 
(15 to 300 μM nucleotide) were digested with a constant 
concentration of 1 μg (1.5 μM) of CdtB, the maximum nu-
clease activity (over 70% digestion) was observed when the 
DNA concentration was below 0.2 μg (30 μM nucleotide). 
At concentrations of DNA above 0.4 μg (60 μM nucleo-
tide), the effi ciency of digestion by CdtB nuclease was re-
duced and remained around 40% during the 6 h incubation 
period. Incubation of 1 μg (150 μM nucleotide) eukaryotic 
DNA with 1 μg (1.5 μM) of CdtB yielded similar results; 
53% digestion during the 6 h incubation. Digestion with 1 
μg (1.5 μM) CdtB and 1 μg (150 μM nucleotide) plasmid 
DNA revealed a linear relationship and an average diges-
tion of 6.1 ± 1.2% of DNA/h (1.5 μM nucleotides/h; a spe-
cifi c activity of 1 M nucleotides/h/M enzyme). By contrast, 
0.1 U (3.7 μM) of bovine pancreatic DNase I hydrolyzed 
80% of 1 μg (150 μM nucleotide) of either plasmid or eu-
karyotic DNA within 20 min (specifi c activity of 97 M nu-
cleotides/h/M enzyme). Therefore, CdtB nuclease was 97-
fold less active than DNase I.
Comparative analysis of the predicted amino acid se-
quence of H. hepaticus CdtB with members of the mam-
malian DNase I family indicates that although the DNA hy-
drolysis residues are highly conserved  [9,23], only fi ve of 
15 DNA binding residues, namely E37, S93, R139, N190, 
and T224 are present in CdtB (personal observation). The 
absence of several essential residues in CdtB may account 
for reduced effi ciency of plasmid and eukaryotic DNA di-
gestion compared with DNase I.
The cation-dependence of the DNase I family of nucle-
ases is well-established  [22–24], and although cation-bind-
ing sites are present in CdtB, the requirements for specifi c 
cation(s) for nuclease activity have not been investigated. 
To determine the cation requirement for nuclease activ-
ity of CdtB, recombinant CdtB was incubated with plas-
mid DNA in the presence of increasing concentrations of 
CaCl2, MgCl2, and NaCl. CdtB had no activity when incu-
bated in the absence of either Ca2+ or Mg2+, whereas maxi-
mum activity was seen at concentrations of 20 and 15 mM 
of the respective divalent cation (Fig. 3). Moreover, CdtB 
nuclease activity showed a synergistic effect when the con-
centration of one cation was reduced while the other cat-
ion was kept unchanged (10 mM). The nuclease activity 
of CdtB was impaired at concentrations of Ca2+ and Mg2+ 
above 20 and 15 mM, respectively (Fig. 3). Complete in-
hibition was present by chelation of divalent cations with 
a concentration of EDTA greater or equal to 20 mM (data 
not shown). Based on these observations, we concluded 
that CdtB is a Ca2+ and Mg2+-dependent nuclease similar 
to DNase I  [22–24].
Monovalent ions, including Na+, K+, and NH4
+ are 
known inhibitors of mammalian DNase I activity [24]. The 
nuclease activity of CdtB was impaired at a concentration 
of 50 mM NaCl, and complete inhibition was found at a 
concentration of 250 mM NaCl (Fig. 3). This effect might 
be attributable to an increase in the ionic strength of the so-
lution rather than a direct binding of the Na+ ions to the 
cation-binding site of CdtB.
The nuclease activity of members of the DNase I family 
is completely inhibited by Zn2+ ion  [22,24], therefore we 
determined the 50% inhibition concentration (IC50) of Zn
2+ 
Figure 3. Nuclease activity of H. hepaticus CdtB in the presence of Ca2+, 
Mg2+, and Na+ salts. His6-tagged CdtB and plasmid DNA (pTRE2-hyg, 
Clontech) were incubated with increasing concentrations of CaCl2, MgCl2, 
and NaCl for 6 h and the remaining undigested double stranded DNA con-
centrations were determined by fl uorometric assay. The nuclease activity of 
CdtB was impaired at concentrations of CaCl2, MgCl2, and NaCl above 20, 
15, and 50 mM, respectively. The data are representative of three indepen-
dent experiments.
224  DASSANAYAKE, GRIEP, & DUHAMEL IN FEMS MICROBIOLOGY LETTERS 251 (2005)
Figure 5. Inhibition of H. hepaticus CdtB nuclease activity by G-actin. His6-
tagged CdtB (closed circles) or bovine pancreatic DNase I (opened circles) 
were pre-incubated with increasing concentrations of G-actin for 20 min fol-
lowed by the addition of plasmid DNA (pTRE2hyg, Clontech) and further in-
cubation for 6 h for CdtB and 20 min for DNase I. The concentration of undi-
gested double stranded DNA was determined by using the fl uorometric assay. 
Greater than 400 μg ml –1 of G-actin was required to inhibit 50% (IC50) of 
CdtB nuclease activity compared with approximately 100 μg ml –1 for DNase 
I. The data are representative of three independent experiments.
Figure 4. Inhibition of H. hepaticus CdtB nuclease activity by ZnCl2. His6-
tagged CdtB (closed circles) or bovine pancreatic DNase I (opened circles) 
were pre-incubated with increasing concentrations of ZnCl2 for 15 min fol-
lowed by the addition of plasmid DNA (pTRE2hyg, Clontech) and further in-
cubation for 6 h for CdtB and 20 min for DNase I. The concentration of undi-
gested double stranded DNA was determined by using the fl uorometric assay. 
Approximately 1.0 mM of ZnCl2 was required to inhibit 50% (IC50) of CdtB 
nuclease activity compared with approximately 0.06 mM for DNase I. The 
data are representative of three independent experiments.
for CdtB. In the fl uorometric assay, the IC50 of Zn
2+ for bo-
vine pancreatic DNase I and CdtB were 0.06 and 1.0 mM, 
respectively (Fig. 4). This data further suggested that CdtB 
is a nuclease similar to members of the mammalian DNase 
I family, however, CdtB was 17-fold more resistant to inhi-
bition by Zn2+ than DNase I.
Monomeric actin, G-actin, binds to bovine and human 
DNase I and inhibits their nuclease activities  [22,25]. The 
nuclease activity of CdtB was partially resistant to inhibi-
tion by G-actin; the IC50 of CdtB was greater than 400 μg 
ml 1 (the highest concentration that could be tested) com-
pared with a IC50 of approximately 100 μg ml
1 for bovine 
pancreatic DNase I (Fig. 5). The inability of G-actin to in-
hibit CdtB correlates with the nonconservation of the DN-
ase I actin-binding residues: Glu13, His44, Asp53, Tyr65, 
Val67, and Glu69 in this protein. The resistance of CdtB 
to inhibition by G-actin, a precursor cytoskeletal protein, 
might allow evasion of the nuclease from inhibition during 
translocation to the eukaryotic cell nucleus.
Although CdtB produced by H. hepaticus has structural 
characteristics homologous to members of the mammalian 
DNase I family, hydrolysis of DNA by CdtB was less active 
and also more resistant to inhibition by Zn2+ and G-actin 
than DNase I. Because CdtB is broadly distributed among 
bacterial pathogens and has nuclease activity in vitro that 
correlates with eukaryotic cell toxicity  [8,9] and pathoge-
nicity in animal models  [5,11–13], it is unique among bac-
terial toxins. The novel and sensitive fl uorometric assay 
provides the fi rst detailed characterization of the biochem-
ical properties of CdtB nuclease for bacterial pathogens in 
general and H. hepaticus in particular. These observations 
provide a framework for comparative biochemical analysis 
of this novel family of bacterial toxins.
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